Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Marts 2013

Planlagt Fastgjort Låst Flyttet Genmab
190 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • D Offline
    D Offline
    deleted-user
    wrote on sidst redigeret af
    #38

    ja mon ikke de tager den i fase 3. Det vil jeg tro de gør 75-25

    1 Reply Last reply
    0
    • SolsenS Offline
      SolsenS Offline
      Solsen
      wrote on sidst redigeret af
      #39

      Link Preview Image
      Domain Registered at Safenames

      favicon

      (www.biomedexperts.com)

      1 Reply Last reply
      0
      • SolsenS Offline
        SolsenS Offline
        Solsen
        wrote on sidst redigeret af
        #40

        Link Preview Image
        New drugs might give heart patients an edge

        (HealthDay)—In the search for better medicines to safely help heart patients, clinical trials testing three new drugs appear to offer some promise.

        favicon

        Medical Xpress (medicalxpress.com)

        1 Reply Last reply
        0
        • SolsenS Offline
          SolsenS Offline
          Solsen
          wrote on sidst redigeret af
          #41

          Sidst i linket siges at større forsøg er på v ej

          1 Reply Last reply
          0
          • D Offline
            D Offline
            deleted-user
            wrote on sidst redigeret af
            #42

            Hvem er ham Tardif?

            1 Reply Last reply
            0
            • MadsSkjernM Offline
              MadsSkjernM Offline
              MadsSkjern
              wrote on sidst redigeret af
              #43

              Hotshot kardiolog i Canada http://www.genomequebec.com/1149-investigator/jean-claude-tardif.html

              1 Reply Last reply
              0
              • D Offline
                D Offline
                deleted-user
                wrote on sidst redigeret af
                #44

                jeg kan ikke rigtigt åbne det link

                1 Reply Last reply
                0
                • MadsSkjernM Offline
                  MadsSkjernM Offline
                  MadsSkjern
                  wrote on sidst redigeret af
                  #45

                  Jean-Claude Tardif is presently the director of the research center at the Montreal Heart Institute, professor of medicine at the University of Montreal, and founder of the new University of Montreal Pharmacogenomics Centre. Dr. Tardif is a world leader in cardiovascular research and has made groundbreaking contributions to the fields of atherosclerosis and biomarkers to assess anti-atherosclerotic therapies. He has published 180 scientific articles in prestigious journals, written 25 book chapt

                  1 Reply Last reply
                  0
                  • D Offline
                    D Offline
                    deleted-user
                    wrote on sidst redigeret af
                    #46

                    ok.

                    1 Reply Last reply
                    0
                    • G Offline
                      G Offline
                      gentogen
                      wrote on sidst redigeret af
                      #47

                      Duo Body http://www.pnas.org/content/early/2013/03/08/1220145110.full.pdf+html

                      1 Reply Last reply
                      0
                      • G Offline
                        G Offline
                        gentogen
                        wrote on sidst redigeret af
                        #48

                        This superior activity does, however, suggest that some antibody
                        pairs may benefit more from a bsAb approach than from a combination
                        strategy.

                        1 Reply Last reply
                        0
                        • G Offline
                          G Offline
                          gentogen
                          wrote on sidst redigeret af
                          #49

                          using cFAE to create bsIgG1 ensures a proper in
                          vivo half-life, intact Fc effector functions, and good manufacturability
                          while retaining a regular IgG structure.

                          1 Reply Last reply
                          0
                          • G Offline
                            G Offline
                            gentogen
                            wrote on sidst redigeret af
                            #50

                            Proof-of-concept studies with HER2×CD3 (T-cell recruitment)
                            and HER2×HER2 (dual epitope targeting) bsAbs demonstrate
                            superior in vivo activity compared with parental antibody pairs.

                            1 Reply Last reply
                            0
                            • D Offline
                              D Offline
                              deleted-user
                              wrote on sidst redigeret af
                              #51

                              Just a moment...

                              favicon

                              (www.pnas.org)

                              1 Reply Last reply
                              0
                              • D Offline
                                D Offline
                                deleted-user
                                wrote on sidst redigeret af
                                #52

                                det her link er måske bedre

                                1 Reply Last reply
                                0
                                • 1 Offline
                                  1 Offline
                                  120281
                                  wrote on sidst redigeret af
                                  #53

                                  går gang i Gen igen idag. 5% oppe.

                                  1 Reply Last reply
                                  0
                                  • G Offline
                                    G Offline
                                    gentogen
                                    wrote on sidst redigeret af
                                    #54

                                    Clinical trials tæller 93 ofatumumab idag efter langtid at have haft 92. Jeg kan bare ikke finde det nye ...

                                    1 Reply Last reply
                                    0
                                    • G Offline
                                      G Offline
                                      gentogen
                                      wrote on sidst redigeret af
                                      #55

                                      Tror det er denne http://www.clinicaltrials.gov/ct2/show/NCT01809847?term=ofatumumab&lup_s=03%2F08%2F2013&lup_e=03%2F13%2F2013&rank=2

                                      1 Reply Last reply
                                      0
                                      • SolsenS Offline
                                        SolsenS Offline
                                        Solsen
                                        wrote on sidst redigeret af
                                        #56

                                        Det bliver interessant om Winkel vil sælge nogle af de tegnede aktier - eller om han går planken ud 🙂

                                        1 Reply Last reply
                                        0
                                        • investor1989I Offline
                                          investor1989I Offline
                                          investor1989
                                          wrote on sidst redigeret af
                                          #57

                                          Har det her været fremme?? http://finance.yahoo.com/news/aeterna-zentaris-discontinue-phase-3-151500409.html en af Daratumumabs konkurrenter allerede i phase III har stoppet udviklingen.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger